Superdisintegrants Market with COVID-19 Impact Analysis, By Type (Natural, and Synthetic), By Formulation (Tablets, and Capsules), By Therapeutic Area and By Region Industry Analysis, Market Size, Market Share & Forecast from 2022-2028
REPORT HIGHLIGHT
The Superdisintegrants Market size was valued at USD 490.7 Million in 2021, expanding at a CAGR of 7.2% from 2022 to 2028.
Superdisintegrants are one of the various excipient types utilized in the pharmaceutical industry for tablet-based medication administration. To assist them to dissolve when submerged in a liquid, superdisintegrants are added to solid dosage forms like pills or tablets. The tablet's increased surface area from breaking into smaller pieces speeds up medication release.
Market Dynamics:
The development of unique superdisintegrant mixtures is a significant advancement in the pharmaceutical sector. With the help of these preparations, manufacturers now have access to a wide range of superdisintegrants, such as co-processed excipients, which are made up of several synthetic superdisintegrants, natural and synthetic superdisintegrants, or synthetic superdisintegrants combined with other pharmaceutical excipients. The active components' fast action, helps to improve the way medications work. Disintegrants are specifically developed for use in the direct compression method of tablet formulations, which eliminates several wet and dry granulation-related processing steps. One of the fastest-growing drug delivery methods using superdisintegrants for direct compression is oral disintegrating tablets (ODTs). A favorable regulatory environment in the developed regions is also progressively supporting growth in the acceptance of innovative excipients. The creation and application of novel excipients have been supported by the International Pharmaceutical Excipients Council (IPEC). To reduce the expense and uncertainty associated with the use of innovative excipients in pharmaceutical formulations, the council has established a novel excipient review approach as an independent process. Therefore, the emergence of new superdisintegrants in the pharmaceutical industry is expected to drive market growth during the forecast period.
However, despite the expanding usage of excipients in medicines, the market for superdisintegrants still has a difficult time meeting up to the high standards set by regulators, consumers, drug manufacturers, and—most importantly—patients. Superdisintegrant production variations have an impact on both the important quality characteristics and the efficacy of drugs. Superdisintegrant concentration fluctuations from supplier to supplier or batch to batch have an impact on the interaction between excipients and drugs, which in turn has an impact on drug efficacy and quality.
COVID-19 Analysis:
The ongoing COVID-19 pandemic had a big effect on the bioanalytical and pharmaceutical industries, especially in the areas of therapeutic research and backing for ongoing drug trials. The dynamics of the industry were somewhat influenced by the difficulties faced by various existing procedures in managing the reduction in manpower at sites and the increased workloads for other COVID-19-related support. However, shortly, the business might slowly come back into existence due to increasing awareness of the higher risk of coronavirus infection among neurological patients. It has been demonstrated that in some patients, an overreactive reaction to the virus raises the risk of dementia, stroke, vascular diseases, and encephalitis. Orally disintegrating tablets are frequently employed as a therapy option for patients with neurological problems like these, therefore drug production is projected to experience a considerable increase, which will ultimately lead to good growth for the industry as a whole.
Geography: Segment Analysis
With the largest revenue share in the superdisintegrants market in 2021, North America dominated the market. A few significant market drivers are the rise in demand for generic medications, improved innovation in the production of superdisintegrants, and manufacturing methods. Additionally, some of the most prominent players in the market for superdisintegrants are based in North America.
However, during the projected period, Asia Pacific is anticipated to develop at the fastest rate. Growth in the Asia Pacific region is anticipated to be fueled by aspects such as rising outsourcing of excipients, including superdisintegrants, production of new superdisintegrants, and adoption of novel technologies (New drug delivery system).
Recent Development:
- In March 2021, Formulationbio announced the Launch of Disintegrant Excipients for Pharmaceutical Preparation.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SUPERDISINTEGRANTS MARKET KEY PLAYERS
- BASF SE
- DuPont
- Ashland Global Holdings Inc.
- Roquette Frères
- DFE Pharma
- JRS PHARMA
- Asahi Kasei Corporation
- Merck KGaA
- Corel Pharma Chem
- Avantor Performance Materials
- NIPPO SODA CO., LTD.
- Sigachi Industries
- Colorcon
- NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
GLOBAL SUPERDISINTEGRANTS MARKET, BY TYPE
- Natural Superdisintegrants
- Synthetic Superdisintegrants
- Others
GLOBAL SUPERDISINTEGRANTS MARKET, BY FORMULATION
- Tablets
- Capsules
GLOBAL SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA
- Gastrointestinal Diseases
- Neurological Diseases
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Inflammatory Diseases
GLOBAL SUPERDISINTEGRANTS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Superdisintegrants Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by Formulation
2.1.3. Market Snippet by Therapeutic Area
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. Superdisintegrants Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Superdisintegrants Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Superdisintegrants Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Superdisintegrants Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Superdisintegrants Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
7.1.2. Natural Superdisintegrants
7.1.3. Synthetic Superdisintegrants
7.1.4. Others
8. Superdisintegrants Market – By Formulation
8.1. Overview
8.1.1. Segment Share Analysis, By Formulation, 2021 & 2028 (%)
8.1.2. Tablets
8.1.3. Capsules
9. Superdisintegrants Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2021 & 2028 (%)
9.1.2. Gastrointestinal Diseases
9.1.3. Neurological Diseases
9.1.4. Oncology
9.1.5. Infectious Diseases
9.1.6. Cardiovascular Diseases
9.1.7. Hematological Diseases
9.1.8. Inflammatory Diseases
10. Superdisintegrants Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.5. North America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. BASF SE
11.2.2. DuPont
11.2.3. Ashland Global Holdings Inc.
11.2.4. Roquette Frères
11.2.5. DFE Pharma
11.2.6. JRS PHARMA
11.2.7. Asahi Kasei Corporation
11.2.8. Merck KGaA
11.2.9. Corel Pharma Chem
11.2.10. Avantor Performance Materials
11.2.11. NIPPO SODA CO., LTD.
11.2.12. Sigachi Industries
11.2.13. Colorcon
11.2.14. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
